Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in US Medicare and Commercial Insurance Plans

Autor:	Damian Everhart, Karen L. Rascati, Yunus Meah, Karen Worley
Rok vydání:	2015
Předmět:	Text mining business.industry DPP-4 Inhibitors Health Policy Public Health Environmental and Occupational Health Medicine Bioinformatics business Dipeptidyl peptidase-4
Zdroj:	Value in Health. 18(7):A601-A602
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.09.2066
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5002f4476aad1c1c8cb3af0505bd59 Zobrazit plný text záznamu Full Text from ScienceDirect